| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.24 | 0.06 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.06 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.06 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | -0.072 | 0.06 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.06 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | 0.089 | 0.06 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.06 |
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.06 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | 0.089 | 0.06 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | 0.066 | 0.06 |